Showing results (11-20 of 361) with videos related to
Sort By:
Pageof 37
Cancer Journal (Sudbury, Mass.)|March 23, 2023
The Microbiome and Liver CancerYuta Myojin, Tim F GretenDigestion|June 13, 2017
Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular CarcinomaTobias Eggert, Tim F GretenCancer Medicine|December 21, 2023
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 yearsCecilia Monge, Tim F GretenImmunity|April 12, 2023
A gut response: Modulating chemotherapy efficacy with microbial metabolitesKylynda C Bauer, Tim F GretenJournal of Liver Cancer|June 29, 2023
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular CarcinomaSu Jong Yu, Tim F GretenJournal of Hepatology|January 20, 2020
Gut microbiome in HCC - Mechanisms, diagnosis and therapyRobert F Schwabe, Tim F GretenNature Reviews. Cancer|April 20, 2023
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunityBenjamin Ruf, Tim F Greten, Firouzeh KorangyCellular & Molecular Immunology|November 25, 2020
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cellsBenjamin Ruf, Bernd Heinrich, Tim F GretenHepatology (Baltimore, Md.)|November 1, 2012
Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapiesAustin Duffy, Julia Wilkerson, Tim F GretenCellular Immunology|January 28, 2021
MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic targetChi Ma, Qianfei Zhang, Tim F GretenPageof 37